RMC No. 51-2022: Updated VAT-Exempt Medicines for COVID-19, Hypertension, and Cancer Under the CREATE Act

RMC No. 51-2022 updates the CREATE Act VAT-exempt medicine list for COVID-19, hypertension, and a corrected cancer medicine entry. Businesses dealing in covered medicines should immediately check whether their invoicing, VAT treatment, product master files, and pharmacy or distribution records reflect the latest VAT-exempt medicine list recognized for CREATE Act purposes. RMC No. 51-2022 confirms […]

RMC No. 47-2022: VAT-Exempt COVID-19 Medicines Under the CREATE Act and FDA-Endorsed Updates for Philippine Taxpayers

RMC No. 47-2022 publishes FDA-endorsed updates adding certain COVID-19 treatment medicines to the CREATE Act VAT-exempt medicines list. Businesses selling, purchasing, prescribing, distributing, or accounting for COVID-19 treatment medicines must check whether the medicine is covered by the FDA-endorsed updates to the list of VAT-exempt medicines under the CREATE Act, because covered medicines should be […]

RMO No. 20-2022: Faster ATRIG Processing for VAT-Exempt Imported Drugs and Medicines in the Philippines

RMO No. 20-2022 tightens ATRIG processing for VAT-exempt imported medicines, requiring complete documents and exact FDA description matching. Importers of VAT-exempt medicines for diabetes, high cholesterol, hypertension, cancer, mental illness, tuberculosis, and kidney diseases must now be more exacting with their ATRIG applications: the BIR will stamp an application as received only when the supporting […]

RMC No. 30-2022: Updated VAT-Exempt Medicines List for Cancer, Diabetes, Hypertension, High Cholesterol, Mental Illness, and COVID-19

RMC No. 30-2022 updates the VAT-exempt medicines list under CREATE, covering specified medicines and requiring sellers to review VAT treatment. Pharmacies, hospitals, clinics, drug distributors, importers, and VAT-registered sellers of medicines must immediately verify whether the medicines they sell, dispense, import, or purchase are included in the updated VAT-exempt medicines list endorsed by the Food […]

RMC No. 123-2021: Updated VAT-Exempt COVID-19 Medicines and Vaccine List for Pharmacies, Importers, Hospitals, and Healthcare Suppliers

RMC No. 123-2021 updates the VAT-exempt COVID-19 medicines and vaccine list, affecting pharmacies, hospitals, importers, and healthcare suppliers. Pharmacies, hospitals, healthcare suppliers, importers, distributors, wholesalers, and retailers dealing in COVID-19 medicines must immediately check their product master lists, invoices, point-of-sale systems, and importation records against the updated VAT-exempt list published under RMC No. 123-2021. The […]

RMC No. 81-2021: VAT Exemption for FDA-Listed Medicines, COVID-19 Drugs, Vaccines, and Medical Devices Under CREATE

RMC No. 81-2021 identifies FDA-listed VAT-exempt medicines, COVID-19 drugs, vaccines, and medical devices under CREATE, with key dates. Businesses selling or importing qualifying medicines, COVID-19 treatment drugs and vaccines, and COVID-19 medical devices must treat covered items as VAT-exempt based on the FDA-endorsed list of VAT-exempt products under the CREATE Act. The practical effect is […]